top of page

WHO Guidelines on the public health response to pretreatment HIV drug resistance

Updated: Oct 14, 2021


This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral drug exposure or people with prior ARV exposure who are initiating or reinitiating first-line antiretroviral therapy. It also provides the consensus prevalence or threshold of pretreatment HIVDR to NNRTIs at which specific public health actions are triggered.



Related Posts

See All

Commenti


bottom of page